I LOVE LUND AB CLASS B
NNGM:LOVE.B87.00
SEK
+1.00
(+1.16%)
ISIN
SE0018397648
Return %
Stock
S&P 500
1Y
10.13
14.20
3Y
-5.43
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Björn Englund
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Lund Sweden
- IPO Date
- Sep 23, 2022
- Website
- ilovelund.se
- Similar Companies
- Business
- I Love Lund AB is a Sweden-based investment company that provides early-stage venture capital, growth equity financing, and strategic advisory services to innovative enterprises with a connection to the Lund and broader Skåne regional innovation ecosystem. Founded in 2017 and headquartered in Lund, Sweden, the company operates as a specialized investment and networking vehicle connecting local entrepreneurs with private and institutional capital. The company delivers a structured range of investment products and corporate services, including: early-stage venture capital financing spanning pre-seed, seed, and Series A funding rounds; direct equity investments through active minority shareholding; strategic board representation, commercialization mentorship, and growth advisory; co-investment syndication and business angel network collaboration; shareholder community activities, investor meeting forums, and entrepreneurial matchmaking programs; and secondary liquidity management through selected holdings in publicly traded regional growth companies. The company focuses its investment activities across a diverse spectrum of high-growth technology and knowledge-intensive sectors, encompassing life sciences, biotechnology, medical technology, software and information technology, telecommunications, defense systems, advanced materials, and environmental technology. I Love Lund AB manages a diversified portfolio of approximately 50 operating companies, primarily targeting privately held, entrepreneur-led ventures situated in southern Sweden. In recent developments, I Love Lund AB has expanded its portfolio through direct investments and capital contributions to emerging technology firms, including nanotechnology platform provider Aligned Bio AB, defense technology firm Valkyr Defense Systems AB, and hospital clean-air ventilation specialist Avidicare AB. The company also achieved a notable portfolio exit following the acquisition of its cancer diagnostics portfolio holding, Saga Diagnostics AB, by Roche subsidiary Foundation Medicine. To support continuous portfolio deployment and follow-on financing rounds, the company completed a rights issue of Class B shares and secured an expanded authorization mandate from shareholders to execute future share and warrant issuances for strategic growth and investment operations.